Quick Takeaways
- John Vavricka has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $671,526.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of John Vavricka
- Location
- Boston, MA
- Summary
- The estimated net worth of John Vavricka is at least $671,526 dollars as of 03 Feb 2026. John Vavricka is the Chief Commercial Officer of Atea Pharmaceuticals, Inc. and owns shares of Atea Pharmaceuticals, Inc. (AVIR) stock worth about $671.5K.
- Signature
- /s/ Andrea Corcoran, as Attorney-in-Fact for John Vavricka
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow John Vavricka and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Atea Pharmaceuticals, Inc. ($671,526).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of John Vavricka
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Chief Commercial Officer | $671,526 | 31 Jan 2026 |
Insider Transactions Reported by John Vavricka:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.